Headline
The latest stories from AHA Today.
In observance of Children’s Mental Health Awareness Week May 4-10, the Health Resources and Services Administration highlighted its Pediatric Mental Health Care Access program that is available to provide free teleconsultation services for health professionals to help them better care for children…
President Trump yesterday announced that Casey Means, M.D., has been nominated to be the next U.S. surgeon general.
Reps. Jennifer McClellan, D-Va., and Don Bacon, R-Neb., and Sens. Jeff Merkley, D-Ore., and Cindy Hyde-Smith, R-Miss., today reintroduced AHA-supported legislation addressing mental health and substance use disorder facility shortages.
An estimated 7.2 million Americans are living with Alzheimer's disease, according to the latest annual report by the Alzheimer's Association.
Nurse leader and suicide survivor Bob Dent, DNP, R.N., shares his personal struggle with mental health that has continued even while managing a successful career.
In an AHA podcast, Women & Infants Hospital's Shannon Sullivan, president and chief operating officer, and Caron Zlotnick, Ph.D., director of behavioral medicine research, discuss the stigma surrounding maternal mental health, the challenges new mothers face and the innovative programs that are…
Nearly 1 in 10 infants (9.8%) were admitted to a neonatal intensive care unit in 2023, an increase of 13% from 2016, according to a report by the Centers for Disease Control and Prevention. There were increases from 2016 to 2023 for each maternal age, race and Hispanic-origin group, gestational age…
The Centers for Medicare & Medicaid Services is suspending (https://www.cms.gov/search/cms?keys=MIPS+activities+suspended) eight improvement activities for the 2025 performance year for the Merit-based Incentive Payment System under the Physician Fee Schedule.
The Trump administration May 5 issued two executive orders on pharmaceutical manufacturing and life-sciences research.
AHA May 6 submitted comments to the Department of Commerce on its Section 232 national security investigation of pharmaceutical and pharmaceutical ingredients imports.